Hisse detayları

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş

ONCSMSTOCKS | TR | IST | Healthcare | Medical Devices

Profil özetiTRY 91.8Piyasa değeri TRY 2.2B

No local candle data found.

Son tespit edilen formasyonlar / setup’lar

Bu sembol ve seçili yön için son 10 Market Radar sonucu.

FormasyonTFTarama çalışmasıKalite

BullishICT Liquidity Sweep Reversal Setup4H07 Nov 26, 16:1673

BullishOliver Kell Momentum Setup4H07 Nov 26, 16:1673

BullishSupport/Resistance Flip Setup4H07 Nov 26, 16:1675

BullishMA 8/21 Crossover4H07 Nov 26, 16:1679

BullishICT Inverse FVG Setup4H07 Nov 26, 16:1680

BearishICT Optimal Trade Entry (OTE) Setup4H07 Nov 26, 16:1691

BearishICT Order Block Setup4H07 Nov 26, 16:16100

BullishSupport/Resistance Flip Setup15M06 Nov 26, 20:1871

BullishICT Liquidity Sweep Reversal Setup15M06 Nov 26, 20:1873

BullishMA 8/21 Crossover15M06 Nov 26, 20:1876

ONCSM şirket profili

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş (ONCSM), IST borsasında işlem görür. Sektör: Healthcare. Faaliyet alanı: Medical Devices.

Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi manufactures and sells chemotherapy drug preparation kits and equipment in Turkey. The company offers OncoCare Monolitik, an automated chemotherapy drug preparation device; OncoCare Plus, a chemotherapy drug guide; OncoWaste and M-Waste, a hazardous waste sealing system, chemotherapy drugs, cephalosporins, penicillins, infectious waste and toxic laboratory waste; OncoCare Set, a chemotherapy preparation and administration consumables; and Oncocare Infusion Pump. It also provides Oncosem components, such as pinch clamps, roller clamps, 3/4 way connectors, vial adapters, drip chambers, hydrophobic caps, male and rotating luer locks, spikes, taxol filters, check valves, and covers. The company was incorporated in 2008 and is headquartered in Ankara, Turkey.

Şirketin faaliyet açıklaması veri sağlayıcısından özgün dilinde sunulmaktadır.

Yıllık

Yıllık temel veriler

2025 ve önceki yıllık dönem

Toplam gelirTRY 709.1M+44.7%

Net gelirTRY 50.4M+165.1%

Net kâr marjı7.1%+22.9 pp

Hisse başına kâr2.1+165.6%

Toplam borçTRY 86.8M+42.3%

Nakit ve nakit benzerleriTRY 45.4M-22.4%

Net borçTRY 41.4M+1525.2%

Metrik20212022202320242025

Toplam gelir----TRY 292.9M--TRY 347.2M+18.5%TRY 490.2M+41.2%TRY 709.1M+44.7%

Net gelir----TRY -20.8M--TRY -115.2M-454.9%TRY -77.4M+32.8%TRY 50.4M+165.1%

Net kâr marjı-----7.1%---33.2%-368.2%-15.8%+52.4%7.1%+145.0%

Hisse başına kâr-----0.87---4.8-451.3%-3.2+33.3%2.1+165.6%

Serbest nakit akışı----TRY 26.7M--TRY -82.5M-409.4%TRY 81M+198.2%TRY 2.8M-96.6%

Toplam borç----TRY 23.2M--TRY 90M+288.2%TRY 61M-32.2%TRY 86.8M+42.3%

Nakit ve nakit benzerleri----TRY 19.3M--TRY 84.5M+339.1%TRY 58.5M-30.8%TRY 45.4M-22.4%

Net borç----TRY 3.9M--TRY 5.5M+39.9%TRY 2.6M-53.8%TRY 41.4M+1525.2%

Çeyreklik

Çeyreklik temel veriler

Q2 2026 ve geçen yılın aynı çeyreği

Toplam gelirTRY 221.7M-7.2%

Net gelirTRY 24.6M+314.4%

Net kâr marjı11.1%+8.6 pp

Hisse başına kâr1+400.0%

Toplam borçTRY 178M+13.8%

Nakit ve nakit benzerleriTRY 30.1M-46.4%

Net borçTRY 148M+47.5%

MetrikQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Toplam gelir----TRY 216.7M--TRY 155.8M--TRY 185.7M--TRY 239M--TRY 221.7M+2.3%

Net gelir----TRY 207,299--TRY 16.8M--TRY 24.9M--TRY 5.9M--TRY 24.6M+11783.6%

Net kâr marjı----0.1%--10.8%--13.4%--2.5%--11.1%+11516.5%

Hisse başına kâr0.4------0.7------0.2-50.0%1--

Serbest nakit akışı----TRY -11M--TRY -12.3M--TRY 5.9M--TRY -32.4M--TRY 29.1M+365.8%

Toplam borç----TRY 69.3M--TRY 69.6M--TRY 86.8M--TRY 156.5M--TRY 178M+157.0%

Nakit ve nakit benzerleri----TRY 52.7M--TRY 26.8M--TRY 45.4M--TRY 56.2M--TRY 30.1M-42.9%

Net borç----TRY 16.5M--TRY 42.8M--TRY 41.4M--TRY 100.3M--TRY 148M+794.7%

Sahiplik

Kurumsal sahiplik özeti

2026 Q3, quarter ended 2026-08-21

PeriodSahiplikKurumlar13F paylarıToplam yatırımPozisyonlarPut/call

2026 Q32026-08-21